

FOLLOWUS
1. Department of Molecular Pharmacology School of Medicine and Pharmacy Ocean University of China
2. Division of Anti-tumor Pharmacology State Key Laboratory of Drug Research Shanghai Institute of Materia Medica Chinese Academy of Sciences
Online First:23 January 2009,
Published:2008
Scan QR Code
Liu, M., Nie, Q., Xin, X. et al. Identification of AOSC-binding proteins in neurons., Chin. J. Ocean. Limnol. 26, 394–399 (2008). https://doi.org/10.1007/s00343-008-0394-8
Acidic oligosaccharide sugar chain (AOSC)
a D-mannuronic acid oligosaccharide
derived from brown algae polysaccharide
has been completed Phase I clinical trial in China as an anti-Alzheimer’s Disease (AD) drug candidate. The identification of AOSC-binding protein(s) in neurons is very important for understanding its action mechanism. To determine the binding protein(s) of AOSC in neurons mediating its anti-AD activities
confocal microscopy
affinity chromatography
and liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis were used. Confocal microscopy analysis shows that AOSC binds to SH-SY5Y cells in concentration-
time-
and temperature-dependent fashions. The AOSC binding proteins were purified by affinity chromatography and identified by LC-MS/MS analysis. The results showed that there are 349 proteins binding AOSC
including clathrin
adaptor protein-2 (AP-2) and amyloid precursor protein (APP). These results suggest that the binding/entrance of AOSC to neurons is probably responsible for anti-AD activities.
Bodnar, W. M., R. K. Blackburn and J. M. Krise, 2003. Exploiting the complementary nature of LC/MALDI/ MS/MS and LC/ESI/MS/MS for increased proteome coverage. Journal of the American Society for Mass Spectrometry 14(9): 971–979.
Christian, H. and J. S. Dennis, 2007. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid â-peptide. Nature Reviews Molecular Cell Biology 8: 101–112.
Fan, Y., J. Hu and X. L. Xin, 2005. Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms. Neuroscience Letters 374(3): 222–226.
Hu, J. F., M. Y. Geng and X. L. Xin, 2004. Acidic oligosaccharide sugar chain, a marine-derived acidic oligosaccharide, inhibits the cytotoxicity and aggregation of amyloid beta protein. Journal of Pharmacological Sciences 95(2): 248–255.
Kirchhausen, T., 2000. Clathrin. Annual Review of Biochemistry 69(1): 699–727.
Kirchhausen, T., 1999. Adaptors for clathrin-mediated traffic. Annual Review of Cell Biology and Developmental Biology 15: 705–732.
Lindahl, B., C. Westling and G. Gimenez-Gallego, 1999. Common binding sites for beta-amyloid fibrils and fibroblast growth factor-2 in heparan sulfate from human cerebral cortex. Journal of Biological Chemistry 274: 30 631–30 635.
Rauk, A., 2008. Why is the amyloid beta peptide of Alzheimer’s disease neurotoxic? Dalton Transactions 10: 1 273–1 282.
Selkoe, D. J., T. Yamazaki, and M. Citron, 1996. The role of APP processing and trafficking pathways in the formation of amyloid beta-protein. Annals of the New York Academy of Sciences 777(1): 57–64.
Tanzi, R. E. and L. Bertram, 2001. New frontiers in Alzheimer’s disease genetics. Neuron 32(2): 181–184.
Vassar, R., B. D. Bennett and S. Babu-Khan, 1999. Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286: 735–741.
Williamson, T. G., S. S. Mok and A. Henry, 1996. Secreted glypican binds to the amyloid precursor protein of Alzheimer’s disease (APP) and inhibits APP-induced neurite outgrowth. Journal of Biological Chemistry 271(49): 31 215–31 221.
0
Views
1
Downloads
5
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621